The baroreceptor as a therapeutic target for heart failure

Journal of Cardiovascular Translational Research

Volumn 7, Issue 3, 2014, Pages 301-309

  Gronda, Edoardo ^a   Lovett, Eric G ^b   Tarascio, Michela ^c   Georgakopoulos, Dimitrios ^b   Grassi, Guido ^d   Vanoli, Emilio ^a,c  

^a IRCCS MULTIMEDICA   (Italy)

^b CVRX INC   (United States)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Autonomic nervous system; Baroreflex; Heart failure; Non pharmacologic therapy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; MOXONIDINE; PROPRANOLOL; VASODILATOR AGENT;

ACUTE HEART FAILURE; ACUTE HEART INFARCTION; ANGINA PECTORIS; CARDIAC RESYNCHRONIZATION THERAPY; DEVICE THERAPY; DRUG EFFICACY; DRUG MECHANISM; ELECTROSTIMULATION THERAPY; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HUMAN; LEFT VENTRICULAR ASSIST DEVICE; NERVE STIMULATOR; NEUROMODULATION; NONHUMAN; PATHOPHYSIOLOGY; PRESSORECEPTOR; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PULSE GENERATOR; RESISTANT HYPERTENSION; REVIEW; SPINAL CORD STIMULATION; SYMPATHETIC TONE; ANIMAL; AUTONOMIC NERVOUS SYSTEM; DISEASE MODEL; DRUG EFFECTS; HEART ASSIST DEVICE; HEART VENTRICLE REMODELING; PHYSIOLOGY;

ANIMALIA;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; PRESSORECEPTORS; VENTRICULAR REMODELING;

EID: 84899457353     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-014-9546-8     Document Type: Review

References (71)

1. Harris, A. S., Estandia, A., & Tillotson, R. F. (1951). Ventricular ectopic rhythms and ventricular fibrillation following cardiac sympathectomy and coronary occlusion. American Journal of Physiology, 165, 505-512.
2. Cerati, D., & Schwartz, P. J. (1991). Single cardiac vagal fiber activity, acute myocardial ischemia, and risk for sudden death. Circulation Research, 69, 1389-1401.
3. Schwartz, P. J., Pagani, M., Lombardi, F., Malliani, A., & Brown, A. M. (1973). A cardiocardiac sympathovagal reflex in the cat. Circulation Research, 32, 215-220.
4. Schwartz, P. J., La Rovere, M. T., & Vanoli, E. (1992). Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation, 85, I77-I91.
5. La Rovere, M. T., Pinna, G. D., Hohnloser, S. H., Marcus, F. I., Mortara, A., Nohara, R., et al. (2001). Autonomic tone and reflexes after myocardial infarcton. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: Implications for clinical trials. Circulation, 103, 2072-2077. (Pubitemid 32373010)
6. Rundqvist, B., Eisenhofer, G., Elam, M., & Friberg, P. (1997). Attenuated cardiac sympathetic responsiveness during dynamic exercise in patients with heart failure. Circulation, 95, 940-945. (Pubitemid 27091537)
7. Fu, Q., Zhang, R., Witkowski, S., Arbab-Zadeh, A., Prasad, A., Okazaki, K., et al. (2005). Persistent sympathetic activation during chronic antihypertensive therapy: A potential mechanism for long term morbidity? Hypertension, 45, 513-521. (Pubitemid 40411252)
8. Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Jr., Ferdinand, K., et al. (2004). Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. New England Journal of Medicine, 351, 2049-2057.
9. Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., et al. (1984). Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. New England Journal of Medicine, 311, 819-823. (Pubitemid 14035089)
10. Levine, T. B., Francis, G. S., Goldsmith, S. R., Simon, A. B., & Cohn, J. N. (1982). Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. American Journal of Cardiology, 49, 1659-1666. (Pubitemid 12003477)
11. St John Sutton, M., Pfeffer, M. A., Moye, L., Plappert, T., Rouleau, J. L., Lamas, G., et al. (1997). Cardiovascular death and left ventricular remodeling two years after myocardial infarction: Baseline predictors and impact of long-term use of captopril: Information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation, 96, 3294-3299. (Pubitemid 27513397)
12. Grassi, G., Cattaneo, B. M., Seravalle, G., Lanfranchi, A., Pozzi, M., Morganti, A., et al. (1997). Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation, 96, 1173-1179. (Pubitemid 27344220)
13. Poole-Wilson, P. A., & Katz, A. M. (2002). Future strategies of reverse remodeling: Summation. Journal of Cardiac Failure, 8, S556-S561. (Pubitemid 36083112)
14. Bristow, M. R., Gilbert, E. M., Abraham, W. T., Adams, K. F., Fowler, M. B., Hershberger, R. E., et al. (1996). Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators. Circulation, 94, 2807-2816. (Pubitemid 26411745)
15. Bristow, M. R. (2000). Mechanistic and clinical rationales for using beta-blockers in heart failure. Journal of Cardiac Failure, 6(2 Suppl 1), 8-14.
16. Lowes, B. D., Gilbert, E. M., Abraham, W. T., Minobe, W. A., Larrabee, P., Ferguson, D., et al. (2002). Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. New England Journal of Medicine, 346, 1357-1365. (Pubitemid 34754608)
17. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353:2001-2007.
18. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial. Lancet 353:9-13.
19. Packer, M., Fowler, M. B., Roecker, E. B., Coats, A. J., Katus, H. A., Krum, H., et al. (2002). Effect of carvedilol on the morbidity of patients with severe chronic heart failure: Results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation, 106, 2194-2199. (Pubitemid 35222212)
20. Willenheimer, R., van Veldhuisen, D. J., Silke, B., Erdmann, E., Follath, F., Krum, H., et al. (2005). Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: Results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III. Circulation, 112, 2426-2435. (Pubitemid 41504492)
21. Vanoli, E., Dei Cas, L., & Willenheimer, R. (2006). Sudden death prevention in heart failure: The case of CIBIS III. Heart International, 2, 73.
22. Cohn, J. N., Pfeffer, M. A., Rouleau, J., Sharpe, N., Swedberg, K., Straub, M., et al. (2003). Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON). European Journal of Heart Failure, 5, 659-667. (Pubitemid 38043972)
23. Floras, J. S. (2002). The "unsympathetic" nervous system of heart failure. Circulation, 105, 1753-1755.
24. Li, M., Zheng, C., Sato, T., Kawada, T., Sugimachi, M., & Sunagawa, K. (2004). Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation, 109, 120-124. (Pubitemid 38056032)
25. Angell-James, J. E., & George, M. J. (1978). Carotid sinus baroreceptor reflex and baroreflex control of the circulation in experimental cardiovascular disease. Journal of Physiology, 275, 38P-39P.
26. Wang, W., Chen, J. S., & Zucker, I. H. (1990). Carotid sinus baroreceptor sensitivity in experimental heart failure. Circulation, 81, 1959-1966. (Pubitemid 20183845)
27. Lu, Y., Ma, X., Sabharwal, R., Snitsarev, V., Morgan, D., Rahmouni, K., et al. (2009). The ion channel ASIC2 is required for baroreceptor and autonomic control of the circulation. Neuron, 64, 885-897.
28. Bronk, D. W., & Stella, G. (1932). Afferent impulses in the carotid sinus nerve. Journal of Cellular and Comparative Physiology, 1, 113.
29. De Castro, F. (1928). Sur la structure et l'innervation du sinus carotidien de l'homme et des mammifères. Nouveaux faits sur l'innervation et la fonction du glomus caroticum. Etudes anatomiques et physiologiques. Trab Laboratory Investigation Biol Univ Madrid, 25, 331-380.
30. Cowley, A. W., Jr., Liard, J. F., & Guyton, A. C. (1973). Role of baroreceptor reflex in daily control of arterial blood pressure and other variables in dogs. Circulation Research, 32, 564-576.
31. Sakamoto K, Hosokawa K, Tobushi T, Onitsuka K, Fujino T, Saku K, Kakino T, Ikeda M, Ide T, Sunagawa K (2013) Salt loading in the presence of baroreflex failure predisposes to pulmonary edema in conscious rats with normal left ventricular function. Circulation 128: A16538.
32. Markham, D. W., Fu, Q., Palmer, M. D., Drazner, M. H., Meyer, D. M., Bethea, B. T., et al. (2013). Sympathetic neural and hemodynamic responses to upright tilt in patients with pulsatile and nonpulsatile left ventricular assist devices. Circulation. Heart Failure, 6, 293-299.
33. Francis, G. S., Benedict, C., Johnstone, D. E., Kirlin, P. C., Nicklas, J., Liang, C. S., et al. (1990). Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation, 82, 1724-1729. (Pubitemid 20367975)
34. Smithwick, R. H. (1951). Surgical measures in hypertension. Springfield: Charles C. Thomas.
35. Withering, W. (1785). An account of the foxglove, and some of its medical uses. Birmingham: M. Swinney.
36. Ferguson, D. W., Berg, W. J., Sanders, J. S., Roach, P. J., Kempf, J. S., & Kienzle, M. G. (1989). Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings. Circulation, 80, 65-77. (Pubitemid 19178639)
37. Ahmed, A., Rich, M. W., Love, T. E., Lloyd-Jones, D. M., Aban, I. B., Colucci, W. S., et al. (2006). Digoxin and reduction in mortality and hospitalization in heart failure: A comprehensive post hoc analysis of the DIG trial. European Heart Journal, 27, 178-186. (Pubitemid 43069034)
38. Ahmed, A., Rich, M. W., Fleg, J. L., Zile, M. R., Young, J. B., Kitzman, D. W., et al. (2006). Effects of digoxin on morbidity and mortality in diastolic heart failure: The ancillary digitalis investigation group trial. Circulation, 114, 397-403. (Pubitemid 44264821)
39. Alzamora-Castro, V., Battilana, G., Garrido-Lecca, G., Rubio, C., Abugattas, R., & Bouroncle, J. (1955). Acute left ventricular failure and carotid sinus stimulation. JAMA, 157, 226-229.
40. Schmidli, J., Savolainen, H., Eckstein, F., Irwin, E., Peters, T. K., Martin, R., et al. (2007). Acute device-based blood pressure reduction: Electrical activation of the carotid baroreflex in patients undergoing elective carotid surgery. Vascular, 15, 63-69. (Pubitemid 47026645)
41. Zucker, I. H., Hackley, J. F., Cornish, K. G., Hiser, B. A., Anderson, N. R., Kieval, R., et al. (2007). Chronic baroreceptor activation enhances survival in dogs with pacing-induced heart failure. Hypertension, 50, 904-910. (Pubitemid 350287533)
42. Lohmeier, T. E., Irwin, E. D., Rossing, M. A., Serdar, D. J., & Kieval, R. S. (2004). Prolonged activation of the baroreflex produces sustained hypotension. Hypertension, 43, 306-311. (Pubitemid 38174130)
43. Kroon, A., Schmidli, J., Scheffers, I., Tordoir, J., Mohaupt, M., Allemann, Y., et al. (2010). Chronically implanted system: 4-year data of Rheos® DEBuT-HT study in patients with resistant hypertension. Journal of Hypertension, 28(e-suppl A), 278.
44. Bakris, G. L., Nadim, M. K., Haller, H., Lovett, E. G., Schafer, J. E., & Bisognano, J. D. (2012). Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: Results of long-term follow-up in the Rheos Pivotal Trial. Journal of the American Society of Hypertension, 6, 152-158.
45. Bisognano, J. D., Bakris, G., Nadim, M. K., Sanchez, L., Kroon, A. A., Schafer, J., et al. (2011). Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: Results from the double-blind, randomized, placebo-controlled rheos pivotal trial. Journal of the American College of Cardiology, 58, 765-773.
46. Kroon, A., Sica, D., Bisognano, J., Nadim, M., Sanchez, L., & Bakris, G. (2011). Individualized programming demonstrates feasibility of unilateral approach to delivery of Baroreflex Activation Therapy. European Heart Journal, 32(abstract supplement), 645.
47. Hoppe, U. C., Brandt, M. C., Wachter, R., Beige, J., Rump, L. C., Kroon, A. A., et al. (2012). Minimally invasive system for baroreflex activation therapy chronically lowers blood pressurewith pacemaker-like safety profile: Results from the Barostim neo trial. Journal of the American Society of Hypertension, 6, 270-276.
48. Georgakopoulos, D., Little, W. C., Abraham, W. T., Weaver, F. A., & Zile, M. R. (2011). Chronic baroreflex activation: A potential therapeutic approach to heart failure with preserved ejection fraction. Journal of Cardiac Failure, 17, 167-178.
49. Sabbah, H. N. (2012). Baroreflex activation for the treatment of heart failure. Current Cardiology Reports, 14, 326-333.
50. Iliescu, R., Tudorancea, I., Irwin, E. D., & Lohmeier, T. E. (2013). Chronic baroreflex activation restores spontaneous baroreflex control and variability of heart rate in obesity-induced hypertension. American Journal of Physiology - Heart and Circulatory Physiology, 305, H1080-H1088.
51. Lohmeier, T. E., Iliescu, R., Dwyer, T. M., Irwin, E. D., Cates, A. W., & Rossing, M. A. (2010). Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex. American Journal of Physiology - Heart and Circulatory Physiology, 299, H402-H409.
52. Burgoyne S, Georgakopoulos D, Belenkie I, Tyberg JV (2013) Conductance and capacitance effects of acute, electrical baroreflex stimulation: Effects of vasoactive agents. In review.
53. Kamiya, A., Kawada, T., Yamamoto, K., Michikami, D., Ariumi, H., Miyamoto, T., et al. (2005). Dynamic and static baroreflex control of muscle sympathetic nerve activity (SNA) parallels that of renal and cardiac SNA during physiological change in pressure. American Journal of Physiology - Heart and Circulatory Physiology, 289, H2641-H2648. (Pubitemid 41698581)
54. Braunwald, E., Epstein, S. E., Glick, G., Wechsler, A. S., & Braunwald, N. S. (1967). Relief of angina pectoris by electrical stimulation of the carotid-sinus nerves. New England Journal of Medicine, 277, 1278-1283.
55. Dunning, A. J. (1971). Electrostimulation of the carotid sinus nerve in angina pectoris. Amsterdam: Excerpta Medica.
56. Braunwald, E., Sobel, B. E., & Braunwald, N. S. (1969). Treatment of paroxysmal supraventricular trachycardia by electrical stimulation of the carotid-sinus nerves. New England Journal of Medicine, 281, 885-887.
57. Borst, C., & Meijler, F. L. (1984). Baroreflex modulation of ventricular rhythm in atrial fibrillation. European Heart Journal, 5, 870-875. (Pubitemid 15152579)
58. Heusser, K., Tank, J., Engeli, S., Diedrich, A., Menne, J., Eckert, S., et al. (2010). Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension, 55, 619-626.
59. Heusser, K., Tank, J., Engeli, S., Menne, J., Eckert, S., Haller, H., et al. (2010). Baroreflex Activation Therapy® (BAT®) acutely improves central arterial properties in resistant hypertension patients. Journal of Hypertension, 28(e-suppl A), 29.
60. Wustmann, K., Kucera, J. P., Scheffers, I., Mohaupt, M., Kroon, A. A., de Leeuw, P. W., et al. (2009). Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension. Hypertension, 54, 530-536.
61. Georgakopoulos, D., Kroon, A., Bach, D. S., Kaufman, C. L., Abraham, W. T., Little, W. C., et al. (2010). Improved ventricular-arterial elastance following chronic treatment using the Rheos® System implantable device in resistant hypertension. Journal of Cardiac Failure, 6, S27.
62. Bisognano, J. D., Kaufman, C. L., Bach, D. S., Lovett, E. G., de Leeuw, P., & DEBuT-HT and Rheos Feasibility Trial Investigators. (2011). Improved cardiac structure and function with chronic treatment using an implantable device in resistant hypertension: Results from European and United States trials of the Rheos system. Journal of the American College of Cardiology, 57, 1787-1788.
63. Bisognano, J. D., Bakris, G. L., Nadim, M., Sanchez, L., & Sica, D. A. (2011). Baroreflex hypertension therapy improves cardiac structure and function in resistant hypertension: Results from the Pivotal Trial of the Rheos System. Journal of the American College of Cardiology, 57, E491.
64. Segers, P., Vermeersch, S. J., Wachter, R., & Georgakopoulos, D. (2011). Effect of carotid baroreceptor activation on ventricular function and central arterial hemodynamics: A case report based on invasive pressure-volume loop analysis. Artery Research, 5, 166-167.
65. Brandt, M. C., Madershahian, N., Velden, R., & Hoppe, U. C. (2011). Baroreflex activation as a novel therapeutic strategy for diastolic heart failure. Clinical Research in Cardiology, 100, 249-251.
66. Borlaug, B. A., & Paulus, W. J. (2011). Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. European Heart Journal, 32, 670-679.
67. Cohn, J. N. (2004). Blood pressure and the therapy of advanced heart failure. Journal of the American College of Cardiology, 43, 1430-1431.
68. Ruschitzka, F., Abraham, W. T., Singh, J. P., Bax, J. J., Borer, J. S., Brugada, J., et al. (2013). Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. New England Journal of Medicine, 369, 1395-1405.
69. Gronda E, Serravalle G, Brambilla G, Costantino G, Staine T, Moneta A, Casini A, Capritti E, Alsheraei A, Lovett E, Grassi G (2013) Chronic baroreflex activation reduces sympathetic tone and improves clinical outcomes in reduced-ejection fraction heart failure. Circulation 128:A16137
70. Halbach M, Madershahian N, Brandt MC, Ladage D, Velden R, Lovett E, Hoppe UC, Muller-Ehmsen J (2012) Baroreflex activation therapy significantly lowers NTproBNP in patients with symptomatic heart failure. Circulation, 126:A15273.
71. Hamaguchi, S., Kinugawa, S., Sobirin, M. A., Goto, D., Tsuchihashi-Makaya, M., Yamada, S., et al. (2012). Mode of death in patients with heart failure and reduced vs. preserved ejection fraction: Report from the registry of hospitalized heart failure patients. Circulation Journal, 76, 1662-1669.